Proton pump inhibitors and chronic kidney disease risk: a comparative study with histamine-2 receptor antagonists

被引:0
作者
Takhyeon Kweon
Yerim Kim
Kyung Joo Lee
Won-Woo Seo
Seung In Seo
Woon Geon Shin
Dong Ho Shin
机构
[1] Kangdong Sacred Heart Hospital,Department of Internal Medicine, College of Medicine
[2] Hallym University,undefined
关键词
D O I
暂无
中图分类号
学科分类号
摘要
This observational study explored the association between proton pump inhibitor (PPI) and histamine-2 receptor antagonist (H2RA) use and the risk of chronic kidney disease (CKD). Using the National Health Insurance Service-National Sample Cohort (NHIS-NSC) and six-hospital electronic health record (EHR) databases, CKD incidence was analyzed among PPI and H2RA users. Propensity score matching was used to balance baseline characteristics, with 1,869 subjects each in the PPI and H2RA groups from the NHIS-NSC, and 5,967 in EHR databases. CKD incidence was similar for both groups (5.72/1000 person-years vs. 7.57/1000 person-years; HR = 0.68; 95% CI, 0.35–1.30). A meta-analysis of the EHR databases showed no significant increased CKD risk associated with PPI use (HR = 1.03, 95% CI: 0.87–1.23). These results suggest PPI use may not increase CKD risk compared to H2RA use, but the potential role of PPI-induced CKD needs further research. Clinicians should consider this when prescribing long-term PPI therapy.
引用
收藏
相关论文
共 50 条
[1]  
Savarino V(2018)Appropriateness in prescribing PPIs: a position paper of the italian society of gastroenterology (SIGE) - Study section "Digestive Diseases in Primary Care" Digest. Liver Dis.: Official J. Italian Soc. Gastroenterol. Italian Assoc. Study of the Liver 50 894-902
[2]  
Tosetti C(2013)Proton-pump inhibitor use is associated with low serum magnesium concentrations Kidney Int. 83 692-699
[3]  
Benedetto E(2015)Proton pump inhibitors and hypomagnesemia in the general population: a population-based cohort study Am. J. Kidney Dis. 66 775-782
[4]  
Compare D(2015)Proton pump inhibitors and the risk of acute kidney injury in older patients: a population-based cohort study CMAJ Open 3 E166-171
[5]  
Nardone G(2013)Proton pump inhibitors and acute kidney injury: a nested case-control study BMC Nephrol. 14 150-385
[6]  
Danziger J(2006)Proton pump inhibitors and acute interstitial nephritis: report and analysis of 15 cases Nephrology (Carlton, Vic.) 11 381-823
[7]  
Kieboom BC(2007)Proton pump inhibitor-induced acute interstitial nephritis Br. J. Clin. Pharmacol. 64 819-604
[8]  
Antoniou T(2006)Proton pump inhibitors and acute interstitial nephritis Clin. Gastroenterol. Hepatol.: Official Clin. Practice J. Am. Gastroenterol. Assoc. 4 597-246
[9]  
Klepser DG(2016)Proton pump inhibitor use and the risk of chronic kidney disease JAMA Intern. Med. 176 238-3163
[10]  
Collier DS(2016)Proton pump inhibitors are associated with increased risk of development of chronic kidney disease BMC Nephrol. 17 112-272